Direxion Daily S&P Biotech Bear 3X ETF
LABD
19 hedge funds and large institutions have $41.2M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 3 closing their positions.
513% more call options, than puts
Call options by funds: $14.8M | Put options by funds: $2.42M
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
146% more capital invested
Capital invested by funds: $16.8M → $41.2M (+$24.5M)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
12% more funds holding
Funds holding: 17 → 19 (+2)
19.46% less ownership
Funds ownership: 41.31% → 21.85% (-19%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$7.05M |
| 2 |
HF
HRT Financial
New York
|
+$6M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.76M |
| 4 |
CA
CHI Advisors
New York
|
+$4.85M |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$4.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$947K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$370K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$310K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$149K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$25.4K |
LABD Hedge Fund Activity: Q2 2023 in Review
19 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q2 2023, worth a combined $41.2M — up 146% from $16.8M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new LABD positions and 3 closed out — a net gain of 2 holders — while 10 added to existing stakes and 3 trimmed.
The largest buyer was Virtu Financial, adding an estimated $7.05M. The largest seller was Jane Street, cutting an estimated $947K.
- 19 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q2 2023, up from 17 in Q1 2023.
- Funds reported $41.2M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q2 2023, up 146% quarter-over-quarter.
- 5 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q2 2023 and 3 closed out, a net change of +2 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q2 2023 was Virtu Financial, an estimated $7.05M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q2 2023 was Jane Street, an estimated $947K sold.
Based on aggregated 13F filings for Q2 2023.